Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Pierre Fabre Medicament
Pierre Fabre Medicament
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
SymBio Pharmaceuticals
Baylor College of Medicine
Baylor College of Medicine
National Institutes of Health Clinical Center (CC)
Maisonneuve-Rosemont Hospital
BGI, China
Atara Biotherapeutics
Beijing Friendship Hospital
National Institutes of Health Clinical Center (CC)
University of Miami
Cell Medica Ltd
Cell Medica Ltd
RedHill Biopharma Limited
National Institutes of Health Clinical Center (CC)
West Virginia University
St. Justine's Hospital
Queensland Institute of Medical Research
Children's Healthcare of Atlanta
Cancer Research UK
National Institute of Allergy and Infectious Diseases (NIAID)